Intravenous iron treatment has a shorter infusion time and fewer adverse adverse events when ferric carboxymaltose is used compared to iron polymaltose, a study in women at a Victorian maternity service has shown. Clinicians at the Royal Women’s Hospital in Melbourne made the observation after they switched from iron polymaltose (Ferrum H injection) to ferric carboxymaltose (Ferinject) ...
Intravenous iron products differ on infusion times and adverse reactions
By Michael Woodhead
6 Mar 2018